Skip to main content
Terug
Watch Compare

BIOTRICITY INC.

Datakwaliteit: 100%
BTCY
OTC Manufacturing Measuring & Analyzing Instruments
€ 0,25
▼ € 0,01 (-2,00%)
Marktkapitalisatie: 7,01 M
Prijs
€ 0,25
Marktkapitalisatie
7,01 M
Dagbereik
€ 0,25 — € 0,27
52-Weeksbereik
€ 0,20 — € 0,75
Volume
40.100
Openen € 0,27
50D / 200D Gem.
€ 0,26
4,03% below
50D / 200D Gem.
€ 0,42
42,24% below

Quick Summary

Belangrijkste Punten

Revenue grew 42,07% annually over 5 years — strong growth
Negative free cash flow of -1,10 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 27,75%
Interest coverage of 0,09× — tight debt servicing

Groei

Revenue Growth (5Y)
42,07%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)14,32%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-25,99%
Op. Margin0,91%

Veiligheid

Debt / Equity
N/A
Current Ratio0,21
Interest Coverage0,09

Waardering

PE (TTM)
-1,74
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDA55,94
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -1,7 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % -26,0 -41,5
Rev Growth 5Y % 42,1 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 14,32% Revenue Growth (3Y) 19,61%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 42,07% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 15,45 M Net Income (TTM) -4,02 M
ROE N/A ROA -66,88%
Gross Margin 81,09% Operating Margin 0,91%
Net Margin -25,99% Free Cash Flow (TTM) -1,10 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,21
Interest Coverage 0,09 Asset Turnover 2,57
Working Capital -18,82 M Tangible Book Value -34,24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,74 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,45
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 55,94 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -15,68%
Market Cap 7,01 M Enterprise Value 7,90 M
Per Share
EPS (Diluted TTM) -0,16 Revenue / Share 0,54
FCF / Share -0,04 OCF / Share -0,04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 27,36%
SBC-Adj. FCF -1,17 M Growth Momentum -27,75

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 13,79 M 12,06 M 9,64 M 7,65 M 3,38 M
Net Income -8,42 M -14,09 M -18,66 M -29,13 M -15,49 M
EPS (Diluted) -0,56 -1,66 — — —
Gross Profit 10,56 M 8,36 M 5,44 M 4,57 M 1,51 M
Operating Income -2,45 M -8,83 M -15,41 M — —
EBITDA — — — — —
R&D Expenses 2,16 M 2,57 M 3,23 M 2,74 M 2,06 M
SG&A Expenses 10,86 M 14,61 M 17,62 M — —
D&A — — — — —
Interest Expense 364.000,0 3,02 M 1,84 M 379.500,0 —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5,64 M 5,94 M 6,51 M 16,68 M 4,44 M
Total Liabilities 35,66 M 35,92 M 26,36 M 18,82 M 11,27 M
Shareholders' Equity -32,01 M -31,47 M -19,85 M -2,14 M -6,83 M
Total Debt — — — — —
Cash & Equivalents 365.145,0 786.060,0 570.460,0 12,07 M 2,20 M
Current Assets 4,64 M 4,47 M 4,72 M 15,32 M 4,32 M
Current Liabilities 20,64 M 22,70 M 11,16 M 4,87 M 10,49 M